The Eu­ro­pean Med­i­cines Agency has flipped its stance on Ei­sai and Bio­gen’s Alzheimer’s treat­ment Leqem­bi, ...

This brand offers a bunch of beds, but what should you know about their most popular AS3 mattress before you buy it for ...

Next-generation metagenomic sequencing test developed at UCSF proves its effectiveness in quickly diagnosing almost any kind ...

Microorganisms—bacteria, viruses and other tiny life forms—may drive biological variation in visible life as much, if not ...

The company has discontinued the Phase I/II trial of its only clinical candidate due to a potential “unfavourable ...

Bluebird bio Inc., which nine years ago was worth nearly as much as the airline JetBlue, said it's now looking for enough ...

The Eu­ro­pean Com­mis­sion is ask­ing bio­phar­ma and man­u­fac­tur­ing com­pa­nies about their re­ac­tion to No­vo ...

Gabbard has been accused of spreading Russian propaganda and former Secretary of State Hillary Rodham Clinton once referred ...

UCSF researchers develop customizable SNIPR sensors that activate engineered cells only near tumors, promising precise cancer ...

BridgeBio Pharma’s acoramidis shows improved survival data, boosting approval chances. Read why BBIO stock could see gains if ...

Sensei Biotherapeutics is laying off 46% of its workforce as the cancer-focused biotech looks to preserve cash to take its ...

The Biotechnology Innovation Organization (BIO) has commended a recent update from the USDA's Animal and Plant Health Inspection Service (APHIS), which has expanded exemptions for genetically modified ...